8legs: U.s. department of health and human services

Your Followed Topics

#1 out of 4

The HEALTH AI Act would establish a grant program under the Public Health Service Act to fund AI research in healthcare.
Projects must focus on reducing clinician administrative burden and speeding claims processing.
The act would require prioritizing projects that aid medically underserved populations and reduce disparities.
Generative AI could be used to draft clinical notes and automate routine documentation.
Oversight and safety measures include guardrails, sandboxes, and accountability for AI deployments.
The bill cites potential to reduce clinician time on diagnostics by enabling AI-assisted tasks.
The HEALTH AI Act aims to modernize healthcare while maintaining patient safety and ethics.
Legislation would authorize funding for academic and federal centers to partner with healthcare providers.
The act exposes the risk of AI bias and 'black box' decisions in clinical settings.
Early emphasis is on administrative efficiency to support frontline clinicians.

Vote 0

#2 out of 4

The U.S. named 15 drugs for Medicare price negotiations effective in 2028, under the Inflation Reduction Act.
Biktarvy and Xeljanz are among the drugs selected for price talks, reflecting IRA goals to reduce patient costs.
The 2028 list also includes treatments administered in doctors’ offices and hospitals, such as Cosentyx and Botox.
Analysts say negotiated prices beginning in 2028 could be manageable for the industry.
CMS said the selected drugs accounted for about $27 billion in U.S. spending over the year ending Oct. 31, 2025.
The IRA has sparked court challenges from drugmakers opposing government price setting.
Analysts noted several selected medicines may lose exclusivity soon, affecting pricing dynamics.
The list includes drugs from Gilead, Lilly, AbbVie, Johnson & Johnson, Pfizer, and Bristol Myers
The selection process targeted medicines with reduced generic competition and long development times.
The government hopes negotiated prices will save billions for Medicare residents when fully implemented.
The 2028 negotiations reflect ongoing efforts to curb prescription drug costs under the IRA.

Vote 0

#3 out of 43.4K est. views

The Administration for Children and Families warned Mississippi it could still face a substantial penalty for TANF fund misuse.
HHS says Mississippi could face penalties even after the prior $100 million penalty was rescinded.
The letter was sent to Mississippi’s Department of Human Services, outlining ongoing concerns over TANF fund misspending.
Analysts say the exchange reflects broader questions about regulatory processes in fraud cases across states.
The HHS letter asks for an update on efforts to substantiate nearly $100 million in payments linked to nonprofit intermediaries.

Vote 0

#4 out of 4

The latest Fox News coverage explains the new dietary guidelines that shift away from fixed daily alcohol limits.
Experts say there are no cardiovascular benefits to drinking alcohol, and less is better.
Women metabolize alcohol differently, increasing certain health risks compared to men, doctors say.
Medical professionals recommend discussing personal risk with a primary care doctor, especially with relevant family history.
Experts caution that heavy drinking raises risks for atrial fibrillation, high blood pressure, and certain cancers.
Physicians emphasize abstinence as the safest option to reduce alcohol-related risks.
The report notes that even moderate drinking can impair driving and interact with medications.
Dr. Mark Hyman and other doctors discuss increased cancer risk for some groups due to hormonal factors.
The coverage includes expert opinions on the lack of cardiovascular benefits tied to alcohol.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.